Alpha Teknova, Inc.
TKNOAlpha Teknova is a specialized producer of critical reagents used in the discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics.
Earnings
Next report
Nov 5, 2026 (in 2 months)Competitors
By market cap
By revenue growth
Profile
Alpha Teknova is a specialized producer of critical reagents used in the discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. The company leverages proprietary manufacturing processes to provide high-quality, custom-formulated reagents with significantly faster turnaround times than traditional suppliers. Their value proposition centers on being a trusted partner that can scale with customers from early-stage research to GMP-compliant commercial production.
A leading provider of custom reagents distinguished by rapid turnaround times and the ability to transition customers from research-grade to GMP-grade materials.
FAQ
- What is Alpha Teknova, Inc.'s market cap?
- Alpha Teknova, Inc. (TKNO) has a market capitalization of $381.7M and trades on NASDAQ.
- Who are Alpha Teknova, Inc.'s competitors?
- Alpha Teknova, Inc.'s key competitors include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, and others. These companies compete in similar markets and product categories.
- Where is Alpha Teknova, Inc. headquartered?
- Alpha Teknova, Inc. is headquartered in United States of America and employs approximately 211 people. It has been publicly traded since 2021.